Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 913articles · 365d
- 5+ hour agolatest article
- Sep 14, 2025earliest in window
- 95%with images
- 285avg words
- Medical 573
- Business & Industrial 538
- Economy, Business & Finance 451
- Health & Wellness 337
- Health 267
- Finance & Business 254
- Science & Technology 156
- Science & Nature 42
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Pharmaceutical Executive Daily: David Samra Calls For Novartis Board Shake-Up
2+ day, 9+ hour ago (382+ words) David Samra Calls For Novartis Board Shake-Up | PharmExec Pharmaceutical Executive Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry In today's Pharmaceutical Executive Daily, Artisan Partners' David Samra calls for…...
Artisan Partners??? Director Calls for Novartis Board Shake-Up
2+ day, 12+ hour ago (362+ words) Artisan Partners' David Samra is publicly calling for Novartis to overhaul its board and compensation structure following back-to-back trial failures. A major shareholder in Novartis calls for a shake-up of the Swiss drugmaker's board to improve corporate governance, after the…...
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B
4+ day, 4+ hour ago (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...
Aptar and Aceso Therapeutics Enter Collaboration for Cystic Fibrosis Therapy
4+ day, 14+ hour ago (243+ words) Aptar Pharma and Aceso Therapeutics have partnered to advance ACT-101, an antisense oligonucleotide targeting the underlying mechanisms of cystic fibrosis. Aptar Pharma entered a collaboration with Aceso Therapeutics to advance development of ACT-101, an antisense oligonucleotide candidate designed to target…...
Moving Beyond the Sample Size Guess: Lessons from 60 Million Clinical Trial Simulations
2+ week, 3+ day ago (118+ words) Pharmaceutical Executive Why traditional power calculations leave asset value on the table, and how adaptive frameworks change the math on risk. Most Phase 2 trials are sized on a guess seen as mathematics. You are in the trial design meeting, your…...
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2+ week, 4+ day ago (647+ words) Pharmaceutical Executive...
Focusing on Asset Acquisition Over Building a Single Platform Technology
2+ week, 5+ day ago (199+ words) Pharmaceutical Executive Earlier this year, Pharmaceutical Executive reported on Chinaâs growing prominence in the pharma and biotech spaces During this year, billions of dollars have been committed to licensing commitments with Chinese companies, with many US-based companies making up…...
Your Questions Answered: What This Week's Rare Disease and Specialty Drug News Tells Us About Where the Industry Is Heading
3+ week, 1+ day ago (80+ words) Pharmaceutical Executive Your Questions Answered: What This Week's Rare Disease and Specialty Drug News Tells Us About Where the Industry Is Heading From an approval for a disease affecting 900 people worldwide to a new drug class in multiple myeloma and…...
The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi
3+ week, 2+ day ago (300+ words) Rohit Tripathi, VP of Industry Strategy at RELEX, talks with Pharmaceutical Executive about the impact new phased tariffs will have on reshoring pharma manufacturing. A transcript of Tripathi's conversation with Pharmaceutical Executive can be found below. The other part covers…...
When Drug Pricing Becomes Trade Policy
3+ week, 3+ day ago (1614+ words) How drug pricing, tariffs, and manufacturing decisions are becoming connected. For years, pharmaceutical companies could treat U.S. reimbursement, European market access, trade policy and manufacturing strategy as related but mostly separate issues. That separation is becoming harder to defend. The Administration…...